Downregulation of Adipose Tissue Fatty Acid Trafficking in Obesity
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Lipotoxicity and ectopic fat deposition reduce insulin signaling. It is not clear whether excess fat deposition in nonadipose tissue arises from excessive fatty acid delivery from adipose tissue or from impaired adipose tissue storage of ingested fat. RESEARCH DESIGN AND METHODS: To investigate this we used a whole-body integrative physiological approach with multiple and simultaneous stable-isotope fatty acid tracers to assess delivery and transport of endogenous and exogenous fatty acid in adipose tissue over a diurnal cycle in lean (n = 9) and abdominally obese men (n = 10). RESULTS: Abdominally obese men had substantially (2.5-fold) greater adipose tissue mass than lean control subjects, but the rates of delivery of nonesterified fatty acids (NEFA) were downregulated, resulting in normal systemic NEFA concentrations over a 24-h period. However, adipose tissue fat storage after meals was substantially depressed in the obese men. This was especially so for chylomicron-derived fatty acids, representing the direct storage pathway for dietary fat. Adipose tissue from the obese men showed a transcriptional signature consistent with this impaired fat storage function. CONCLUSIONS: Enlargement of adipose tissue mass leads to an appropriate downregulation of systemic NEFA delivery with maintained plasma NEFA concentrations. However the implicit reduction in adipose tissue fatty acid uptake goes beyond this and shows a maladaptive response with a severely impaired pathway for direct dietary fat storage. This adipose tissue response to obesity may provide the pathophysiological basis for ectopic fat deposition and lipotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2. The rate of appearance (Ra) of NEFA in lean and abdominally obese men shown as total body Ra and adjusted for lean and fat mass, respectively. The Ra of NEFA: whole-body (A), expressed per lean mass (B), and per total fat mass (C) in lean (●) and abdominally obese men (○). Three meals were given as indicated by the dotted vertical lines. The Ra of NEFA (μmol/min) was significantly higher in the abdominally obese group compared with the lean group (A) (time × group, P = 0.009). When the data were calculated and expressed as rate of disappearance (Rd) of NEFA, i.e., normalized per lean body mass (μmol · min−1 [lean mass (kg)]−1), this difference disappeared (P = 0.14). The abdominally obese men had significantly lower Ra of NEFA when expressed per total fat mass (μmol · min−1 [fat mass (kg)]−1, P = 0.029).](https://figures.cochat.ai/paper-figures/291de207979749098f7b18c6e5596291/downregulation-of-adipose-tissue-fatty-acid-trafficking-in-obesity-figure-2.jpg)

![FIG. 4. Total transcapillary flux of fatty acids across adipose tissue (A) in lean (●) and abdominally obese (○) men following ingestion of three meals (as indicated by the dotted vertical lines). B shows the transcapillary flux of [2H2]-palmitate, which is dominated by the label carried in [2H2]-TG (VLDL). C shows the percentage of meal fat content deposited in adipose tissue after three sequential meals (meal 1, meal 2, meal 3) in lean (■) and abdominally obese (□) males. This was calculated from the transcapillary flux (A) where each 5-h time period (AUC) multiplied for body fat mass to arrive at total body fat being stored. The denominator for each time period is the fat content in the meal. Lean men show a significant meal × fractional uptake effect (P = 0.009), whereas the effect is statistically nonsignificant in the abdominally obese men. AT, adipose tissue.](https://figures.cochat.ai/paper-figures/da9e3099304f4af89b70310d4db09623/downregulation-of-adipose-tissue-fatty-acid-trafficking-in-obesity-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The amount of liberated FFA from chylomicrons and VLDL depends on the activity of LPL, which is stimulated by insulin [17,18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [18]
In the citing paper
“Recent work from the Oxford group using arterio-venous blood sampling in adipose tissue with labeled palmitate, elegantly demonstrated impaired fatty acid trapping in vivo in obese men [18].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155 · cited 1×
“An expansion of adipose tissue mass, in particular abdominal obesity, is associated with an increased risk of type 2 diabetes (1), cardiovascular disease (2), insulin resistance (3), and all-cause mortality (4,5).”
BackgroundLewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333 · cited 1×
“It is postulated that adipose tissue acts to “buffer” the influx of dietary fat into the circulation (6,7).”
BackgroundSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933 · cited 1×
“The release of nonesterified fatty acids (NEFAs) from upper-body subcutaneous adipose tissue is a major determinant of systemic NEFA plasma concentrations (9), whereas visceral fat may contribute fatty acids specifically to the liver.”
BackgroundAdipose tissue as a buffer for daily lipid flux
Frayn, K. (2002) · Diabetologia · doi:10.1007/s00125-002-0873-y · Cited by 752 · cited 1×
“It is postulated that adipose tissue acts to ‘buffer’ the influx of dietary fat into the circulation (6; 7).”
BackgroundSelf-citationAbdominal obesity and the development of noninsulin‐dependent diabetes mellitus
Björntorp, P. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040607 · Cited by 294 · cited 1×
“An expansion of adipose tissue mass, in particular abdominal obesity, is associated with an increased risk of type 2 diabetes (1), cardiovascular disease (2), insulin resistance (3) and all-cause mortality (4;”
BackgroundAdipose tissue metabolism in obesity: Lipase action in vivo before and after a mixed meal
Coppack, S. W., Evans, R. D., Fisher, R. M., Frayn, K. N., Gibbons, G. F., Humphreys, S. M., Kirk, M. L., Potts, J. L., & Hockaday, T. D. R. (1992) · Metabolism · doi:10.1016/0026-0495(92)90269-g · Cited by 279 · cited 1×
“After a single meal, the postprandial concentrations of NEFA tend to remain somewhat higher in obese compared with lean people (15; 16).”
BackgroundSelf-citationJocken, J. W. E., Langin, D., Smit, E., Saris, W. H. M., Valle, C., Hul, G. B., Holm, C., Arner, P., & Blaak, E. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1318 · Cited by 264 · cited 3×
“In line with earlier observations for LPL (31) and hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) (32), we found lower expression in obese/insulin-resistant men, but our findings on transcript regulation also indicate a profound lowering of all processes involved in fatty acid trafficking in obe…”
BackgroundInfluentialPreferential Uptake of Dietary Fatty Acids in Adipose Tissue and Muscle in the Postprandial Period
Bickerton, A. S. T., Roberts, R., Fielding, B. A., Hodson, L., Blaak, E. E., Wagenmakers, A. J. M., Gilbert, M., Karpe, F., & Frayn, K. N. (2007) · Diabetes · doi:10.2337/db06-0822 · Cited by 246 · cited 1×
“These findings were corroborated by studying the transcapillary flux of all [(2)H2]palmitate-FA (composite measurement of VLDL-TG and direct uptake of NEFA, where the latter is the minor component (24)).”
Self-citation
Cited by
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Metabolic Flexibility in Health and Disease
Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995
Why does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939
Fatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896
Self-citationThe aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Metabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
Obesity, Inflammation, and Immune System in Osteoarthritis
Nedunchezhiyan, U., Varughese, I., Sun, A. R., Wu, X., Crawford, R., & Prasadam, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907750 · Cited by 466
Physical Activity and Exercise in the Regulation of Human Adipose Tissue Physiology
Thompson, D., Karpe, F., Lafontan, M., & Frayn, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00012.2011 · Cited by 402
Self-citationHow May GIP Enhance the Therapeutic Efficacy of GLP-1?
Samms, R. J., Coghlan, M. P., & Sloop, K. W. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.006 · Cited by 419
Tumour fatty acid metabolism in the context of therapy resistance and obesity
Hoy, A. J., Nagarajan, S. R., & Butler, L. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00388-4 · Cited by 392
Structural and biochemical characteristics of various white adipose tissue depots
Wronska, A., & Kmiec, Z. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02409.x · Cited by 373
“It was shown that gluteofemoral fat presented lower lipolytic activity than subcutaneous abdominal fat (Lafontan & Langin 2009) and preferentially picked up recycled lipids in the form of VLDL and FFA, rather than chylomicrons derived from dietary lipids (McQuaid et al. 2011).”
BackgroundBjørndal, B., Burri, L., Staalesen, V., Skorve, J., & Berge, R. K. (2011) · Journal of Obesity · doi:10.1155/2011/490650 · Cited by 369
Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369
Modulation of adipose tissue inflammation by bioactive food compounds
Siriwardhana, N., Kalupahana, N. S., Cekanova, M., LeMieux, M., Greer, B., & Moustaid-Moussa, N. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.013 · Cited by 345
Fat Depots, Free Fatty Acids, and Dyslipidemia
Ebbert, J., & Jensen, M. (2013) · Nutrients · doi:10.3390/nu5020498 · Cited by 349
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
Hodson, L., & Gunn, P. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0256-9 · Cited by 309
Self-citationCarboxylesterases in lipid metabolism: from mouse to human
Lian, J., Nelson, R., & Lehner, R. (2018) · Protein & Cell · doi:10.1007/s13238-017-0437-z · Cited by 300
“…resistance is associated with increased adipose tissue-derived circulating fatty acid and ectopic lipid accumulation (Karpe et al., 2011; McQuaid et al., 2011), thus approaches that block excessive fatty acid release from adipose tissue and restore normal tissue lipid partitioning often…”
BackgroundChanges in Plasma Free Fatty Acids Associated with Type-2 Diabetes
I. S. Sobczak, A., A. Blindauer, C., & J. Stewart, A. (2019) · Nutrients · doi:10.3390/nu11092022 · Cited by 304
Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 276
Visceral fat and metabolic inflammation: the portal theory revisited
Item, F., & Konrad, D. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01035.x · Cited by 265
Verboven, K., Wouters, K., Gaens, K., Hansen, D., Bijnen, M., Wetzels, S., Stehouwer, C. D., Goossens, G. H., Schalkwijk, C. G., Blaak, E. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22962-x · Cited by 240
An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
Lee, E., Korf, H., & Vidal-Puig, A. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.024 · Cited by 222
Integration of clinical data with a genome‐scale metabolic model of the human adipocyte
Mardinoglu, A., Agren, R., Kampf, C., Asplund, A., Nookaew, I., Jacobson, P., Walley, A. J., Froguel, P., Carlsson, L. M., Uhlen, M., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.5 · Cited by 239
White adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 209
Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction
Laforest, S., Labrecque, J., Michaud, A., Cianflone, K., & Tchernof, A. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1041582 · Cited by 214
Adipose tissue and adipocyte dysregulation
Lafontan, M. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.08.002 · Cited by 207
Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.04.001 · Cited by 166
Pinnick, K. E., Nicholson, G., Manolopoulos, K. N., McQuaid, S. E., Valet, P., Frayn, K. N., Denton, N., Min, J. L., Zondervan, K. T., Fleckner, J., et al. (2014) · Diabetes · doi:10.2337/db14-0385 · Cited by 186
Self-citationLipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults
Rauschert, S., Uhl, O., Koletzko, B., Kirchberg, F., Mori, T. A., Huang, R.-C., Beilin, L. J., Hellmuth, C., & Oddy, W. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3525 · Cited by 187
Adipose tissue and metabolic syndrome: too much, too little or neither
Grundy, S. M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12519 · Cited by 187
Targeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
Postprandial metabolism of meal triglyceride in humans
Lambert, J. E., & Parks, E. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.01.006 · Cited by 182
Mardinoglu, A., Bjornson, E., Zhang, C., Klevstig, M., Söderlund, S., Ståhlman, M., Adiels, M., Hakkarainen, A., Lundbom, N., Kilicarslan, M., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167422 · Cited by 176
Marinou, K., Hodson, L., Vasan, S. K., Fielding, B. A., Banerjee, R., Brismar, K., Koutsilieris, M., Clark, A., Neville, M. J., & Karpe, F. (2014) · Diabetes Care · doi:10.2337/dc13-1353 · Cited by 176
Self-citationParallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity
Trim, W., Turner, J. E., & Thompson, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00169 · Cited by 169
Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
Itoh, M., Suganami, T., Nakagawa, N., Tanaka, M., Yamamoto, Y., Kamei, Y., Terai, S., Sakaida, I., & Ogawa, Y. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.07.014 · Cited by 167
Regulation of human subcutaneous adipose tissue blood flow
Frayn, K. N., & Karpe, F. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.200 · Cited by 173
Self-citationRole of Lipotoxicity in Endothelial Dysfunction
Kim, J., Montagnani, M., Chandrasekran, S., & Quon, M. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.012 · Cited by 163
Ding, C., Shi, Y., Li, J., Li, M., Hu, L., Rao, J., Liu, L., Zhao, P., Xie, C., Zhan, B., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.01.033 · Cited by 159
Diagnosis of obesity based on body composition‐associated health risks—Time for a change in paradigm
Bosy‐Westphal, A., & Müller, M. J. (2021) · Obesity Reviews · doi:10.1111/obr.13190 · Cited by 162
Characterising metabolically healthy obesity in weight-discordant monozygotic twins
Naukkarinen, J., Heinonen, S., Hakkarainen, A., Lundbom, J., Vuolteenaho, K., Saarinen, L., Hautaniemi, S., Rodríguez, A., Frühbeck, G., Pajunen, P., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3066-y · Cited by 162
Metabolic Signatures of Human Adipose Tissue Hypoxia in Obesity
Hodson, L., Humphreys, S. M., Karpe, F., & Frayn, K. N. (2012) · Diabetes · doi:10.2337/db12-1032 · Cited by 159
Self-citationVors, C., Pineau, G., Gabert, L., Drai, J., Louche‐Pélissier, C., Defoort, C., Lairon, D., Desage, M., Danthine, S., Lambert-Porcheron, S., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.043976 · Cited by 145
Restricted Adipogenesis in Hypertrophic Obesity
Gustafson, B., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2013) · Diabetes · doi:10.2337/db13-0473 · Cited by 163
Fryk, E., Olausson, J., Mossberg, K., Strindberg, L., Schmelz, M., Brogren, H., Gan, L., Piazza, S., Provenzani, A., Becattini, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103264 · Cited by 163
The Influence of Dietary Fat on Liver Fat Accumulation
Green, C., & Hodson, L. (2014) · Nutrients · doi:10.3390/nu6115018 · Cited by 156
Self-citationInfluence of Dietary Macronutrients on Liver Fat Accumulation and Metabolism
Parry, S. A., & Hodson, L. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000524 · Cited by 132
Self-citationUpdate on the molecular biology of dyslipidemias
Ramasamy, I. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.033 · Cited by 155
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_13 · Cited by 136
The impact of adiposity on adipose tissue-resident lymphocyte activation in humans
Travers, R. L., Motta, A. C., Betts, J. A., Bouloumié, A., & Thompson, D. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.195 · Cited by 132
Kolditz, C., & Langin, D. (2010) · Current opinion in clinical nutrition and metabolic care · doi:10.1097/mco.0b013e32833bed6a · Cited by 117
Trouwborst, I., Bowser, S. M., Goossens, G. H., & Blaak, E. E. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00077 · Cited by 111
Mancilla, R., Brouwers, B., Schrauwen‐Hinderling, V. B., Hesselink, M. K. C., Hoeks, J., & Schrauwen, P. (2020) · Physiological Reports · doi:10.14814/phy2.14669 · Cited by 127
Alligier, M., Gabert, L., Meugnier, E., Lambert-Porcheron, S., Chanséaume, E., Pilleul, F., Debard, C., Sauvinet, V., Morio, B., Vidal‐Puig, A., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3289 · Cited by 116
Templeman, I., Smith, H. A., Chowdhury, E., Chen, Y.-C., Carroll, H., Johnson-Bonson, D., Hengist, A., Smith, R., Creighton, J., Clayton, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8034 · Cited by 113
CD36 genetics and the metabolic complications of obesity
Love-Gregory, L. D., & Abumrad, N. A. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834bbac9 · Cited by 124
Wang, Z., Shang, P., Li, Q., Wang, L., Chamba, Y., Zhang, B., Zhang, H., & Wu, C. (2017) · Scientific Reports · doi:10.1038/srep46717 · Cited by 113
Bays, H. E., Kirkpatrick, C. F., Maki, K. C., Toth, P. P., Morgan, R. T., Tondt, J., Christensen, S. M., Dixon, D. L., & Jacobson, T. A. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100108 · Cited by 126
“…inadequate to fully hydrolyze the obesity-related increase in circulating triglyceride-rich lipoproteins (i.e., lower functional LPL activity per unit fat mass in patients with obesity [98]), contributing to the common clinical finding of elevated triglyceride levels in patients with obesity [86].”
BackgroundYe, R. Z., Richard, G., Gévry, N., Tchernof, A., & Carpentier, A. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab018 · Cited by 101
Labbé, S. M., Grenier–Larouche, T., Noll, C., Phoenix, S., Guérin, B., Turcotte, É. E., & Carpentier, A. C. (2012) · Diabetes · doi:10.2337/db11-1805 · Cited by 105
The Gut-Adipose-Liver Axis in the Metabolic Syndrome
Konrad, D., & Wueest, S. (2014) · Physiology · doi:10.1152/physiol.00014.2014 · Cited by 97
Loh, N. Y., Neville, M. J., Marinou, K., Hardcastle, S., Fielding, B. A., Duncan, E. L., McCarthy, M. I., Tobias, J. H., Gregson, C. L., Karpe, F., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.01.009 · Cited by 109
Self-citationGluteofemoral Adipose Tissue Plays a Major Role in Production of the Lipokine Palmitoleate in Humans
Pinnick, K. E., Neville, M. J., Fielding, B. A., Frayn, K. N., Karpe, F., & Hodson, L. (2012) · Diabetes · doi:10.2337/db11-1810 · Cited by 110
Self-citationCarpentier, A. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2020 · Cited by 108
The role of intermittent fasting and meal timing in weight management and metabolic health
Templeman, I., Gonzalez, J. T., Thompson, D., & Betts, J. A. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119000636 · Cited by 105
Cederberg, H., Stančáková, A., Kuusisto, J., Laakso, M., & Smith, U. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12289 · Cited by 108
Qiu, Y., Gan, M., Wang, X., Liao, T., Chen, Q., Lei, Y., Chen, L., Wang, J., Zhao, Y., Niu, L., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127042 · Cited by 109
Redox implications in adipose tissue (dys)function-A new look at old acquaintances
Jankovic, A., Korac, A., Buzadzic, B., Otasevic, V., Stancic, A., Daiber, A., & Korac, B. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.018 · Cited by 91
Free Fatty Acids and Their Metabolism Affect Function and Survival of Podocytes
Sieber, J., & Jehle, A. W. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00186 · Cited by 93
N-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic Benefit
Wang, Y., & Huang, F. (2015) · BioMed Research International · doi:10.1155/2015/581469 · Cited by 95
Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion
Mizgier, M. L., Casas, M., Contreras‐Ferrat, A. E., Llanos, P., & Galgani, J. E. (2014) · Obesity Reviews · doi:10.1111/obr.12166 · Cited by 97
Hodson, L., Eyles, H. C., McLachlan, K. J., Bell, M. L., Green, T., & Skeaff, C. M. (2013) · Journal of Nutrition · doi:10.3945/jn.113.183749 · Cited by 98
Self-citationJácome-Sosa, M., Borthwick, F., Mangat, R., Uwiera, R. R. E., Reaney, M. J. T., Shen, J., Quiroga, A. D., Jacobs, R. L., Lehner, R. S., Proctor, S. D., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.011 · Cited by 94
Management of Obesity in Cardiovascular Practice
Després, J.-P., Carpentier, A. C., Tchernof, A., Neeland, I. J., & Poirier, P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.035 · Cited by 87
Fielding, B. A. (2011) · Proceedings of The Nutrition Society · doi:10.1017/s002966511100084x · Cited by 102
Self-citationStorage of Circulating Free Fatty Acid in Adipose Tissue of Postabsorptive Humans
Koutsari, C., Ali, A. H., Mundi, M. S., & Jensen, M. D. (2011) · Diabetes · doi:10.2337/db11-0154 · Cited by 85
Impact of Lipotoxicity on Tissue “Cross Talk” and Metabolic Regulation
Montgomery, M. K., Nardo, W. D., & Watt, M. J. (2019) · Physiology · doi:10.1152/physiol.00037.2018 · Cited by 93
Liu, Y., Liu, X., Guan, H., Zhang, S., Zhu, Q., Fu, X., Chen, H., Tang, S., Feng, Y., & Kuang, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.736073 · Cited by 74
Hodson, L., Banerjee, R., Rial, B., Arlt, W., Adiels, M., Borén, J., Marinou, K., Fisher, C., Mostad, I. L., STRATTON, I. M., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002258 · Cited by 84
Self-citationFerrannini, E., Iozzo, P., Virtanen, K. A., Honka, M., Bucci, M., & Nuutila, P. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy162 · Cited by 80
Metabolic Effects of Obesity and Its Interaction with Endocrine Diseases
Clark, M., & Hoenig, M. E. (2016) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2016.04.004 · Cited by 94
Validity of visceral adiposity estimates from DXA against MRI in Kuwaiti men and women
Mohammad, A., Rolfe, E. D. L., Sleigh, A., Kivisild, T., Behbehani, K., Wareham, N. J., Brage, S., & Mohammad, T. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2016.38 · Cited by 75
Mobilising vitamin D from adipose tissue: The potential impact of exercise
Hengist, A., Perkin, O. J., Gonzalez, J. T., Betts, J. A., Hewison, M., Manolopoulos, K. N., Jones, K. S., Koulman, A., & Thompson, D. (2019) · Nutrition Bulletin · doi:10.1111/nbu.12369 · Cited by 80
“…to adrenergic stimulation compared with adipose from individuals without obesity (Reynisdottir et al. 1994; Large et al. 1999; Hellstrom & Reynisdottir 2000), coinciding with decreased gene expression of ATGL and HSL (Large et al. 1999; Langin et al. 2005; Jocken et al. 2007; McQuaid et al. 2011).”
BackgroundEffects of bariatric surgery on lipid-lipoprotein profile
Piché, M., Tardif, I., Auclair, A., & Poirier, P. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154441 · Cited by 77
Short Term Voluntary Overfeeding Disrupts Brain Insulin Control of Adipose Tissue Lipolysis
Scherer, T., Lindtner, C., Zieliński, E., O’Hare, J., Filatova, N., & Buettner, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307348 · Cited by 73
Goto, K., Iso, T., Hanaoka, H., Yamaguchi, A., Suga, T., Hattori, A., Irie, Y., Shinagawa, Y., Matsui, H., Syamsunarno, M. R. A. A., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004861 · Cited by 72
Perdicaro, D. J., Lanzi, C. R., Tudela, J. G., Miatello, R. M., Oteiza, P. I., & Prieto, M. A. V. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108352 · Cited by 69
Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Nagarajan, S. R., Cross, E., Sanna, F., & Hodson, L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003761 · Cited by 71
Self-citationMetabolic syndrome and cardiometabolic risk factors.
Papakonstantinou, E., Lambadiari, V., Dimitriadis, G., & Zampelas, A. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113116660176 · Cited by 68
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Carpentier, A. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.029 · Cited by 71
Pereira, M. J., Skrtic, S., Katsogiannos, P., Abrahamsson, N., Sidibeh, C. O., Dahgam, S., Månsson, M., Risérus, U., Kullberg, J., & Eriksson, J. W. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.008 · Cited by 71
Parry, S. A., Rosqvist, F., Mózes, F. E., Cornfield, T., Hutchinson, M., Piché, M., Hülsmeier, A. J., Hornemann, T., Dyson, P. A., & Hodson, L. (2020) · Diabetes Care · doi:10.2337/dc19-2331 · Cited by 68
Self-citationHodson, L., Harnden, K., Banerjee, R., Real, B., Marinou, K., Karpe, F., & Fielding, B. A. (2014) · Journal of Nutritional Science · doi:10.1017/jns.2013.38 · Cited by 58
Self-citationDadson, P., Landini, L., Helmiö, M., Hannukainen, J. C., Immonen, H., Honka, M.-J., Bucci, M., Savisto, N., Soinio, M., Salminen, P., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1447 · Cited by 60
Metadata
- Authors
- McQuaid, S. E., Hodson, L., Neville, M. J., Dennis, A. L., Cheeseman, J., Humphreys, S. M., Ruge, T., Gilbert, M., Fielding, B. A., Frayn, K. N., & Karpe, F.
- Affiliations
- University of Oxford (GB)
- John Radcliffe Hospital (GB)
- Corresponding author
- Karpe, Fredrik
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-10-13
- Volume
- 60
- Issue
- 1
- Pages
- 47-55
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3012196
- OpenAlex
- W2123627338
- Cited by
- 366
- References
- 32
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 19 · 2023: 24 · 2022: 27 · 2021: 25 · 2020: 15 · 2019: 22 · 2018: 24 · 2017: 26 · 2016: 15 · 2015: 23 · 2014: 32 · 2013: 36 · 2012: 29
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (acceptedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Funders
- American Diabetes Association
- Wellcome Trust
- National Institute for Health and Care Research
- British Heart Foundation
- National Institutes of Health
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- obesity, free fatty acids, ectopic fat deposition, lipotoxicity, insulin signaling, adipose tissue mass, fatty acid uptake, gene expression signatures
- MeSH terms
- Adipose Tissue, Adult, Basal Metabolism, Blood Glucose, Fatty Acids, Nonesterified, Female, Gene Expression Regulation, Humans, Insulin, Cholesterol, HDL, Male, Middle Aged, Obesity, Reference Values, RNA, Messenger, Thinness, Triglycerides, Down-Regulation, Body Mass Index, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.